Key PointsLifeMD is a telehealth platform riding the GLP-1 trend to double-digit revenue growth, with its subscription weight management business driving projected EBITDA growth of 67% in 2024.LifeMD reported Q4 2023 EPS of 15 cents, doubling consensus analyst estimates for a loss of 14 cents, while revenues rose 60% YoY to $44.86 million, beating $40.48 million estimates.LifeMD telehealth subscribers rose 27% YoY to 215, 000 and weight management subscribers exceeded 22,000, up 100% sequentially.5 stocks w ...